Centum Electronics Ltd: Intrinsic Value & Share Price Analysis

Last Updated: December 15, 2025, 1:49 pm

All Competitor Stocks of Centum Electronics Ltd

Last Updated: August 20, 2025, 12:20 pm

Below is a detailed analysis of the quarterly data for Centum Electronics Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 273.40 Cr.. The value appears to be declining and may need further review. It has decreased from 368.74 Cr. (Mar 2025) to 273.40 Cr., marking a decrease of 95.34 Cr..
• For Expenses, as of Jun 2025, the value is 250.68 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 327.19 Cr. (Mar 2025) to 250.68 Cr., marking a decrease of 76.51 Cr..
• For Operating Profit, as of Jun 2025, the value is 22.72 Cr.. The value appears to be declining and may need further review. It has decreased from 41.55 Cr. (Mar 2025) to 22.72 Cr., marking a decrease of 18.83 Cr..
• For OPM %, as of Jun 2025, the value is 8.31%. The value appears to be declining and may need further review. It has decreased from 11.27% (Mar 2025) to 8.31%, marking a decrease of 2.96%.
• For Other Income, as of Jun 2025, the value is 4.71 Cr.. The value appears to be declining and may need further review. It has decreased from 8.12 Cr. (Mar 2025) to 4.71 Cr., marking a decrease of 3.41 Cr..
• For Interest, as of Jun 2025, the value is 6.96 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9.75 Cr. (Mar 2025) to 6.96 Cr., marking a decrease of 2.79 Cr..
• For Depreciation, as of Jun 2025, the value is 10.26 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10.09 Cr. (Mar 2025) to 10.26 Cr., marking an increase of 0.17 Cr..
• For Profit before tax, as of Jun 2025, the value is 10.21 Cr.. The value appears to be declining and may need further review. It has decreased from 29.83 Cr. (Mar 2025) to 10.21 Cr., marking a decrease of 19.62 Cr..
• For Tax %, as of Jun 2025, the value is 56.22%. The value appears to be increasing, which may not be favorable. It has increased from 27.82% (Mar 2025) to 56.22%, marking an increase of 28.40%.
• For Net Profit, as of Jun 2025, the value is 4.48 Cr.. The value appears to be declining and may need further review. It has decreased from 21.53 Cr. (Mar 2025) to 4.48 Cr., marking a decrease of 17.05 Cr..
• For EPS in Rs, as of Jun 2025, the value is 3.05. The value appears to be declining and may need further review. It has decreased from 14.64 (Mar 2025) to 3.05, marking a decrease of 11.59.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Last Updated: December 15, 2025, 5:31 am

Last Updated: September 5, 2025, 1:45 am

Last Updated: December 4, 2025, 1:05 am

Below is a detailed analysis of the balance sheet data for Centum Electronics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 15.00 Cr..
• For Reserves, as of Sep 2025, the value is 390.00 Cr.. The value appears to be declining and may need further review. It has decreased from 391.00 Cr. (Mar 2025) to 390.00 Cr., marking a decrease of 1.00 Cr..
• For Borrowings, as of Sep 2025, the value is 211.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 187.00 Cr. (Mar 2025) to 211.00 Cr., marking an increase of 24.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 779.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 647.00 Cr. (Mar 2025) to 779.00 Cr., marking an increase of 132.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 1,394.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,239.00 Cr. (Mar 2025) to 1,394.00 Cr., marking an increase of 155.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 240.00 Cr.. The value appears strong and on an upward trend. It has increased from 217.00 Cr. (Mar 2025) to 240.00 Cr., marking an increase of 23.00 Cr..
• For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 14.00 Cr..
• For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Other Assets, as of Sep 2025, the value is 1,153.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,007.00 Cr. (Mar 2025) to 1,153.00 Cr., marking an increase of 146.00 Cr..
• For Total Assets, as of Sep 2025, the value is 1,394.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,239.00 Cr. (Mar 2025) to 1,394.00 Cr., marking an increase of 155.00 Cr..

Notably, the Reserves (390.00 Cr.) exceed the Borrowings (211.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

After reviewing the key financial ratios for Centum Electronics Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 1.89. This value is below the healthy minimum of 5. It has increased from 1.38 (Mar 24) to 1.89, marking an increase of 0.51.
• For Diluted EPS (Rs.), as of Mar 25, the value is 1.89. This value is below the healthy minimum of 5. It has increased from 1.38 (Mar 24) to 1.89, marking an increase of 0.51.
• For Cash EPS (Rs.), as of Mar 25, the value is 28.66. This value is within the healthy range. It has decreased from 32.99 (Mar 24) to 28.66, marking a decrease of 4.33.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 275.53. It has increased from 152.63 (Mar 24) to 275.53, marking an increase of 122.90.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 275.53. It has increased from 152.63 (Mar 24) to 275.53, marking an increase of 122.90.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 787.41. It has decreased from 848.11 (Mar 24) to 787.41, marking a decrease of 60.70.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 71.68. This value is within the healthy range. It has decreased from 71.90 (Mar 24) to 71.68, marking a decrease of 0.22.
• For PBIT / Share (Rs.), as of Mar 25, the value is 41.70. This value is within the healthy range. It has increased from 36.77 (Mar 24) to 41.70, marking an increase of 4.93.
• For PBT / Share (Rs.), as of Mar 25, the value is 9.25. This value is within the healthy range. It has increased from 6.11 (Mar 24) to 9.25, marking an increase of 3.14.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -1.31. This value is below the healthy minimum of 2. It has increased from -2.14 (Mar 24) to -1.31, marking an increase of 0.83.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.67. This value is below the healthy minimum of 2. It has increased from 1.38 (Mar 24) to 1.67, marking an increase of 0.29.
• For PBDIT Margin (%), as of Mar 25, the value is 9.10. This value is below the healthy minimum of 10. It has increased from 8.47 (Mar 24) to 9.10, marking an increase of 0.63.
• For PBIT Margin (%), as of Mar 25, the value is 5.29. This value is below the healthy minimum of 10. It has increased from 4.33 (Mar 24) to 5.29, marking an increase of 0.96.
• For PBT Margin (%), as of Mar 25, the value is 1.17. This value is below the healthy minimum of 10. It has increased from 0.72 (Mar 24) to 1.17, marking an increase of 0.45.
• For Net Profit Margin (%), as of Mar 25, the value is -0.16. This value is below the healthy minimum of 5. It has increased from -0.25 (Mar 24) to -0.16, marking an increase of 0.09.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 8. It has increased from 0.16 (Mar 24) to 0.21, marking an increase of 0.05.
• For Return on Networth / Equity (%), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 15. It has decreased from 0.87 (Mar 24) to 0.60, marking a decrease of 0.27.
• For Return on Capital Employeed (%), as of Mar 25, the value is 13.50. This value is within the healthy range. It has increased from 13.22 (Mar 24) to 13.50, marking an increase of 0.28.
• For Return On Assets (%), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 5. It has increased from 0.16 (Mar 24) to 0.19, marking an increase of 0.03.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.21 (Mar 24) to 0.05, marking a decrease of 0.16.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.35. This value is within the healthy range. It has decreased from 0.85 (Mar 24) to 0.35, marking a decrease of 0.50.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.01. It has decreased from 1.02 (Mar 24) to 1.01, marking a decrease of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 1.5. It has increased from 1.08 (Mar 24) to 1.19, marking an increase of 0.11.
• For Quick Ratio (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1. It has increased from 0.62 (Mar 24) to 0.75, marking an increase of 0.13.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.48. This value is below the healthy minimum of 4. It has increased from 1.88 (Mar 24) to 3.48, marking an increase of 1.60.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 157.53. This value exceeds the healthy maximum of 50. It has decreased from 508.22 (Mar 24) to 157.53, marking a decrease of 350.69.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 8.31. This value is below the healthy minimum of 20. It has decreased from 19.17 (Mar 24) to 8.31, marking a decrease of 10.86.
• For Earning Retention Ratio (%), as of Mar 25, the value is -57.53. This value is below the healthy minimum of 40. It has increased from -408.22 (Mar 24) to -57.53, marking an increase of 350.69.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 91.69. This value exceeds the healthy maximum of 70. It has increased from 80.83 (Mar 24) to 91.69, marking an increase of 10.86.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.20. This value is within the healthy range. It has increased from 2.68 (Mar 24) to 3.20, marking an increase of 0.52.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.39. This value is below the healthy minimum of 3. It has increased from 1.06 (Mar 24) to 1.39, marking an increase of 0.33.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,348.24. It has increased from 2,260.16 (Mar 24) to 2,348.24, marking an increase of 88.08.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.03. This value is within the healthy range. It has decreased from 2.07 (Mar 24) to 2.03, marking a decrease of 0.04.
• For EV / EBITDA (X), as of Mar 25, the value is 22.28. This value exceeds the healthy maximum of 15. It has decreased from 24.39 (Mar 24) to 22.28, marking a decrease of 2.11.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.02. This value is within the healthy range. It has increased from 1.98 (Mar 24) to 2.02, marking an increase of 0.04.
• For Retention Ratios (%), as of Mar 25, the value is -57.53. This value is below the healthy minimum of 30. It has increased from -408.22 (Mar 24) to -57.53, marking an increase of 350.69.
• For Price / BV (X), as of Mar 25, the value is 5.78. This value exceeds the healthy maximum of 3. It has decreased from 10.65 (Mar 24) to 5.78, marking a decrease of 4.87.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.02. This value is within the healthy range. It has increased from 1.98 (Mar 24) to 2.02, marking an increase of 0.04.
• For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.00.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks